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ABSTRACT
Introduction: Developed using focus groups, the Oily Skin Self Assess-
ment Scale (OSSAS) and Oily Skin Impact Scale (OSIS) are patient-
reported outcome measures of oily facial skin.
Objective: The aim of this study was to ﬁnalize the item-scale structure of
the instruments and perform psychometric validation in adults with self-
reported oily facial skin.
Methods: The OSSAS and OSIS were administered to 202 adult subjects
with oily facial skin in the United States. A subgroup of 152 subjects
returned, 4 to 10 days later, for test–retest reliability evaluation.
Results: Of the 202 participants, 72.8% were female; 64.4% had self-
reported nonsevere acne. Item reduction resulted in a 14-item OSSAS with
Sensation (ﬁve items), Tactile (four items) and Visual (four items) domains,
a single blotting item, and an overall oiliness item. The OSIS was reduced
to two three-item domains assessing Annoyance and Self-Image. Conﬁr-
matory factor analysis supported the construct validity of the ﬁnal
item-scale structures. The OSSAS and OSIS scales had acceptable item
convergent validity (item-scale correlations >0.40) and ﬂoor and ceiling
effects (<20%). Cronbach’s alpha coefﬁcients ranged from 0.83 to 0.89 for
the OSSAS and 0.82 to 0.87 for the OSIS, demonstrating excellent internal
consistency. The a priori test–retest reliability criterion (intraclass corre-
lation [ICC] 0.7) was met for one of the three OSSAS domains and
one of the two OSIS domains. OSSAS and OSIS domains distinguished
among groups that differed in patient-reported facial oily skin severity
(P < 0.0001), and bother associated with oily skin (P < 0.0001).
Conclusions: The OSSAS and OSIS versions tested in this study have been
found to have strong psychometric properties in this patient sample (adults
with self-reported oily facial skin), as assessments of self-reported oily
facial skin severity and its emotional impact, respectively.
Keywords: item reduction, oily skin, patient-reported outcome, psycho-
metric validation, self-reported acne.
Introduction
Oily skin or seborrhea (ICD-9 code 706.3), is characterized by
excessive sebum production which leads to a person’s skin
appearing shiny and greasy or oily [1–4]. Sebum overproduction
is an important causative factor in a variety of dermatologic
diseases and may be related to seborrheic dermatitis and acne,
thus oil control is an important part of the therapeutic regimen
for these conditions [5–7].
Oily facial skin, with and without acne, can have adverse
psychological and social consequences. Body image can be
affected and many individuals feel embarrassed and annoyed
because of the appearance of their oily skin [8,9]. Oily skin can
be difﬁcult to treat as sebum mixes with topical medications and
cosmetics to destroy the ﬁlm-forming properties necessary for
product functioning.
In order to evaluate the efﬁcacy of treatments of oily facial
skin in clinical trials, it is necessary to have measures of oily facial
skin severity that are valid, reliable, and responsive to changes in
oily skin. Few such measures currently exist. In terms of clinical
measures, the sebumeter and sebutape are both widely used.
However, the validity of both measures has not yet been univer-
sally standardized and there are no published guidelines for
interpreting the meaning of scores or the meaning of changes in
scores.
A patient-reported outcome (PRO) instrument development
program was embarked upon with the aim of developing and
validating PRO measures of oily facial skin that would meet
current standards recommended for PROs as outlined by regu-
latory authorities [10–12]. Two oily skin-speciﬁc questionnaires
have been developed based on face to face and internet focus
groups (IFGs) conducted in adults with oily skin in the United
States and Germany. The Oily Skin Self Assessment Scale
(OSSAS) is a measure of facial oily skin severity and the Oily Skin
Impact Scale (OSIS) assesses the emotional impact of oily facial
skin. The items were developed in both German and English
because future trial and instrument validation work was planned
for Germany. Conceptual frameworks were developed for both
questionnaires, guided by the qualitative focus group results. The
draft questionnaires were reviewed by dermatologists with exper-
tise in quantitative and qualitative oily skin assessment measures
(including the sixth and seventh authors of the present article),
and cognitive debrieﬁng was conducted using Internet and face-
to-face methods. Revisions were then made to the items and
instructions. Details of the questionnaire development process
are provided elsewhere [8,13].
The qualitative research described above was conducted in
adults aged 18 or older. However, following these adult focus
groups, further focus groups in adolescents were conducted for
the purpose of assessing the face and content validity of the
OSSAS in the adolescent population.
The study being reported here involved administering the
OSSAS and OSIS to 202 subjects in the United States, to perform
item reduction and evaluate the validity and reliability of the ﬁnal
instruments.
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Objective
The objective of this study was to ﬁnalize the item-scale struc-
tures of the OSSAS and OSIS and evaluate the psychometric
properties (validity and reliability) of both questionnaires.
Methods
Cross-Sectional Validation Study Design
This was a nonrandomized, cross-sectional, validation study,
conducted at seven locations across the United States and involv-
ing no study treatment. Subjects with oily facial skin were
recruited through advertisements or if they were being treated by
one of the recruiting clinicians. Subjects at two of the sites were
asked to return for a follow-up visit for the purpose of assessing
test–retest reliability. Subjects were enrolled if they met the selec-
tion criteria of the study, detailed below.
Inclusion criteria. Subjects all conﬁrmed by self-assessment that
they had bothersome (“somewhat bothered”) oily facial skin
and had a desire to improve their oily skin. Subjects had to be
willing to not wear facial products at the time of a clinic visit and
willing not to have started a new treatment for oily skin or acne
within 30 days preceding the ﬁrst clinic visit. Subjects with no
acne or mild to moderate acne were included in the sample.
Presence and severity of acne was determined by an acne lesion
count performed by the recruiting clinician. All clinicians were
trained in making acne lesion counts by one of the authors (R.
Rizer) at the start of the study. Mild acne was deﬁned as 2 to 10
inﬂammatory lesions and no nodules on the face: number of
non-inﬂammatory lesions not limited. Moderate acne was
deﬁned as 11 to 40 inﬂammatory lesions and no more than one
small (0.5–1.0 cm) nodule on the face: number of noninﬂamma-
tory lesions not limited. Noninﬂammatory lesions include open
and closed comedones, although inﬂammatory lesions include
papules (elevations of the skin centering on a sebaceous follicle),
pustules (elevations of the skin topped by pus), and nodules
(larger elevations of the skin).
Exclusion criteria. Subjects were excluded if they had severe
facial acne or acne such that it might interfere with either the
clinician’s or subject’s assessment of the oily skin. Subjects were
excluded if they had facial hair, sunburn, or deep tanning of the
face (as assessed from visual inspection by the clinician). Subjects
were also excluded if they were unwilling or unable to comply
with the lifestyle guidelines.
In addition to the inclusion and exclusion criteria, the follow-
ing protocol-speciﬁc lifestyle guideline activity restrictions
applied to all study subjects. For 3 to 4 hours preceding the clinic
visit, subjects were instructed not to:
1. Make any changes to their treatment or daily skin care
routine;
2. Expose their face to intense sunlight or to intense UV rays as
well as any facial tanning;
3. Wear any facial products such as powders, moisturizers, or
cosmetics;
4. Wash, clean, shave, blot, touch, or wipe their face;
5. Do any exercise or anything that might make their skin feel
hot.
The aim of these lifestyle guidelines was to reduce the vari-
ability of subjects’ oily skin because of external factors, and to
reduce the likelihood that perceived oily skin levels might be
biased by factors other than underlying sebum levels, e.g.,
because of sweat or cosmetic creams.
At the baseline visit, the site investigator obtained the sub-
ject’s informed consent and completed a subject medical history.
The investigator then ensured that the subject met all of the
inclusion and exclusion criteria, including being willing to
comply with speciﬁc lifestyle guidelines. Next, the study investi-
gator performed an acne lesion count and completed the Clinical
Global Impression of Severity (CGI-S); for subjects in the
follow-up substudy, a sebumeter [14,15] assessment was also
performed. The subjects then completed the study PRO question-
naires. In addition, the subjects also completed the Skindex-29
[16–18] and the Acne-Speciﬁc Quality-of-Life (Acne-QoL)
[19–21], two oily skin and acne-speciﬁc quality of life measures,
respectively, in order to validate the OSSAS and OSIS against
existing measures. At the end of their ﬁrst visit, subjects in the
follow-up substudy were instructed to follow lifestyle guidelines
within 3 hours prior to their second and ﬁnal visit; this was to
ensure standardized measurements at both visits.
The subset of subjects included in the follow-up substudy
returned for a second visit 7 days (+/- 3 days) after the baseline
visit where they underwent the same study procedures (sebume-
ter reading and acne lesion count) and completed the PRO ques-
tionnaires a second time to allow assessment of the test–retest
reliability of the instruments.
The investigator at each site ensured that each subject was
given full and adequate oral and written information about the
nature, purpose, possible risks, and beneﬁts of the study. The
study was conducted according to the principles of the 1996
amendment of the Declaration of Helsinki and approved by
Copernicus (a centralized ethics committee in the United States).
PRO Measures
OSSAS. The OSSAS is a self-completed PRO measure of facial
skin oiliness. The version of the OSSAS included in this valida-
tion study consisted of a pool of 37 items [8].
OSIS. The version of the OSIS in this validation study included
14 self-completed items that assessed the impact of oily skin on
emotional well-being [8].
Skindex-29. An assessment of oily skin-speciﬁc symptoms, emo-
tions, and functioning were made using the 7-day recall
Skindex-29 [16–18]. The recall period of the Skindex-29 was
adapted to 1 week after consultation with the developer, so that
it was consistent with the other instruments included in the study.
The item response scales range from “never” to “all the time” on
a ﬁve-point Likert scale.
Acne-QoL Questionnaire. For subjects with acne, an assessment
of acne-speciﬁc symptoms, impact on self-perception, and emo-
tional and social functioning was made using the Acne-QoL
[19–21]. The Acne-QoL contains 19 items and asks subjects to
recall over the past week. Responses range from “not at all” to
“extremely” or “extensive” to “none” on a seven-point Likert
scale.
Single-item self-assessment questions. Subjects also completed
three single-item self-assessment questions, included in order to
stratify subjects for known group validity analyses. The three
items assessed subjects’ level of bother from their oily skin
(“Overall, how bothered are you by your oily skin?”); the impor-
tance of improving their oily skin appearance (“How important
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is it to improve the appearance of your skin, speciﬁcally, the areas
that are the most oily?”; and their rating of the level of skin
oiliness (“How do you rate the level of your skin oiliness?”).
Bother and importance response scales ranged from “not at all”
to “extremely” on a ﬁve-point Likert scale, and levels of skin
oiliness were categorized as “none,” “mild,” “moderate,” and
“severe.” Subjects also completed a short, 16-item questionnaire
providing details about demographic and clinical characteristics.
Patient Global Impression (PGI). Subjects were asked to assess
their facial oily skin severity on the most bothersome oily area of
their face (as identiﬁed by the OSSAS) using a PGI of Severity
(PGI-S) item developed for use in this study. Response options
ranged from 1 (“not at all oily”) to 5 (“very severely oily”). At
the second visit, subjects in the follow-up substudy assessed the
change in the oily skin on the most bothersome area of their face
since the start of the study, using a PGI of Change (PGI-C) item,
which was again developed for use in this study. Possible
response options were on a range from 1 (“very much
improved”) to 7 (“very much worse”).
Clinical Measures
Sebumeter. The Sebumeter SM815 (Courage-Khazaka Co.,
Cologne, Germany) [14,15] provides a direct measurement of
skin surface sebum in mg/cm2. For subjects enrolled in the
follow-up substudy, the sebumeter was used to take measure-
ments of forehead sebum at both study visits.
Acne lesion count. For those subjects with acne, the study inves-
tigators performed a facial acne lesion count to assess subjects’
facial acne severity [22]. All investigators received training in
making acne lesions counts prior to commencing the study.
CGI. The investigators made an assessment of the overall sever-
ity of the subject’s facial oily skin using the CGI-S. The CGI-S
rated the severity of four areas of the face (forehead, nose,
cheeks, and chin) on a scale ranging from 1 (“not at all oily”) to
5 (“very severely oily”).
For subjects enrolled in the follow-up substudy, at the second
visit, the study investigators assessed the change in the subject’s
oily skin in the area of the face that was most bothersome to the
subject since the start of the study using the CGI of Change
(CGI-C), with possible response options ranging from 1 (“very
much improved”) to 7 (“very much worse”).
The study investigators were also required to respond to a
single question asking about the overall health status of the
subject, rating the health of the subject as “poor,” “fair,”
“good,” “very good,” or “excellent.”
Item Reduction, Psychometric Validation, and Statistics
A statistical analysis plan for the study was written and ﬁnalized
prior to commencement of the study. Maximum likelihood factor
analysis was performed in order to assess the underlying structure
of the OSSAS and OSIS and to identify potential items for item
reduction. Factor analysis was conducted separately for the
OSSAS and OSIS. Items were considered for deletion on the basis
of a combination of face validity and psychometric characteristics
including: Failure to load on any factor or loaded on more than
one factor; an item-scale correlation of <0.40; correlating at a
higher level with a scale other than the item’s hypothesized scale;
>30% scoring at ﬂoor or ceiling; comments relating to face
validity given by participants in the adolescent focus groups; and
the importance ratings given to the items by the participants in the
IFGs [8].
Following item reduction, the validity and reliability of the
ﬁnal item–scale structures of the OSSAS and OSIS were tested
through further factor analysis and psychometric validation
analyses. Construct validity was evaluated through assessment of
item convergent validity (item-scale correlation 0.40 were con-
sidered acceptable), item discriminant validity (items should cor-
relate more highly with the scale in which they are included than
any other scale in the instrument), and ﬂoor ceiling effects (low
percentages scoring at ﬂoor and ceiling are recommended) [23].
Both internal consistency reliability (Cronbach’s alpha coefﬁcient
should be >0.70) [24,25] and test–retest reliability (intraclass
correlation coefﬁcients for the total score and each item >0.70
[26] for subjects who self-reported that their oily skin was
“unchanged” between baseline and visit 2 on the PGI-C at visit
2) were assessed.
Concurrent validity assessment involves examining corre-
lations between the measure being validated and other well-
validatedmeasures of similar constructs [26]. Domainsmeasuring
similar constructs are expected to correlate highly whereas
domains measuring very different constructs should not correlate.
Here, correlations of OSSAS and OSIS domains with the domains
of the Skindex-29 and Acne-QoL were examined. Known groups
or discriminative validity is the ability of a measure to distinguish
among groups that was expected to differ [27]. OSSAS and
OSIS scores were compared according to PGI-S categories,
CGI-S categories, and single-item self-assessment questions—
bother categories, oiliness categories, and the area of the face
selected as the most bothersome. OSSAS and OSIS groups’ scores
were expected to differ at a statistically signiﬁcant level among
the groups compared. For the OSSAS scores the primary analysis
was the comparison by the PGI-S categories. For the OSIS, the
primary analysis was the comparison by self-reported bother
categories.
The item reduction and validation analyses were conducted
using data for the total cross-sectional sample for all of the
analyses with the exception of the test–retest analyses which were
conducted using data only from those subjects in the follow-up
substudy.
The Type-1 error was 0.05. Pearson’s correlation coefﬁcient
was used to evaluate the correlation between the subscales.
Group comparisons were performed using analysis of variance
(three or more groups) or t test (two groups). Most of the
analyses were performed using SAS version 9.1.3 (SAS Institute,
Inc., Cary, NC) for Windows; multitrait analysis was performed
using “Multitrait Multi-item Analyses Program-Revised”
running on top of SAS version 6.12 for Windows.
Results
The item reduction and cross-sectional psychometric validation
analyses were performed on data from 196 subjects. A total of
152 subjects took part in the follow-up substudy for the purposes
of assessing test–retest reliability. A summary of the demographic
and clinical characteristics of this sample is presented in Table 1.
In the sample of 196 subjects included in the cross sectional
analyses, 72% (n = 142) were female. Subjects were either expe-
riencing mild (n = 19, 9.8%), moderate (n = 124, 63.9%) or
severe oily skin (n = 45, 23.2%), in their own opinion. There was
missing data on this question for eight (4%) subjects. Approxi-
mately two-thirds of subjects had acne (125, 64.4%) according
to their own self report. Sixty-ﬁve subjects self-rated their acne as
mild, 55 self-rated their acne as moderate, and 15 self-rated their
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acne as being severe; none of the subjects thought they had severe
acne.
Item Reduction of the OSSAS
Following the initial data analysis, a number of items were
deleted. Items were deleted because of:
1. being introductory items that became inappropriate because
of a change in the focus of the questionnaire; the revised
questionnaire assesses the face as a whole rather than one
selected area as in the original version;
2. having poor face and content validity, based on feedback
from the adolescent focus groups;
3. having poor psychometric properties;
4. not being relevant or important for the measurement of the
concept of oily skin.
Following item reduction, the conceptual framework for the
OSSAS was revised. The ﬁnal OSSAS item-scale structure con-
sists of three multiitem domains that assess subjects’ oily facial
skin through Visual (three items), Tactile (four items), and
Sensory (ﬁve items) methods (Fig. 1). A single blotting item was
retained but not included as part of a domain score. In addition,
based on the adolescent focus groups, it is recommended that
two additional items be added: “How greasy does your face
feel?” and “How oily is the skin on your face?” It is anticipated
that the “greasy” item will likely be included in the “Sensation”
scale and that the item “How oily is the skin on your face?” will
be scored as a single item as a measure of overall facial skin
oiliness. Revision of the response options to rate the skin on a
scale of “Not at all” to “Extremely” on a 0 to 10 scale is also
recommended based on ﬁndings from the adolescent focus
groups, which suggested that the original response options were
hard to understand.
OSSAS Psychometric Validation
Construct validity. Maximum likelihood factor analysis was per-
formed on the ﬁnal OSSAS items with the number of factors ﬁxed
at four to reﬂect the four domains as hypothesized in the con-
ceptual framework. Four items asking subjects to rate the “sen-
sation” of their oily facial skin (without looking at or touching
their face) loaded on the ﬁrst factor (factor loadings 0.61–0.80)
and were included in the Sensation scale. The blotting item and
three items that ask about the feeling of oily skin to touch loaded
on the second factor (factor loadings 0.54–0.87), and with the
exception of the blotting item were included in the Tactile scale.
The Blotting item was scored on its own because it was felt to be
measuring a distinct concept from a face validity perspective.
Three items that pertain to the look of oily skin loaded on the
third factor (factor loadings 0.42–0.74). A single item (“Overall,
how oily does your skin look?”) loaded on the fourth factor on
its own (factor loading 0.65) but was included in the Visual scale
for reasons of face validity.
The results demonstrate that the OSSAS shows excellent
scaling properties in this sample (Table 2). All of the items in each
domain met the criteria for item convergent validity, correlating
with the other items in that domain (adjusted for overlap) at a
level of >0.40. All items met the criteria for item discriminant
validity correlating at a higher level with their own domain than
any other OSSAS domain.
All correlations among the OSSAS domain scores were mod-
erate (range 0.49–0.66), indicating that the scales are measuring
related but not redundant concepts (Table 2). There were no
signiﬁcant ﬂoor or ceiling effects and, none of the scales had
overly skewed response distributions.
Reliability. The Sensation, Visual, and Tactile scales had Cron-
bach’s alpha coefﬁcients of 0.86, 0.83 and 0.89, respectively
(Table 2), indicating excellent internal consistency reliability.
The threshold for acceptable test–retest reliability
(ICC  0.70) [24] was met by the OSSAS Sensation scale
(ICC = 0.71) but not by the Visual (ICC = 0.64) and Tactile
(ICC = 0.63) scales or the Blotting item (ICC = 0.62) (Table 2).
Concurrent validity. The concurrent validity of the OSSAS was
assessed by examining correlations of its domains with those of
the Skindex-29 and Acne-QoL. All correlations between the
OSSAS and Skindex-29 domains could be considered small,
ranging from 0.20 to 0.38. However, this is unsurprising as the
OSSAS is focused on oily skin symptoms whereas the Skindex-29
assesses symptoms, emotions, and functioning related to skin
conditions.
Correlations between the OSSAS and Acne-QoL domains
were all small or negligible, ranging from -0.10 to -0.35. Again,
this ﬁts with expectations given that the two instruments are
measuring very different concepts.
Known groups validity. The primary test of known group valid-
ity was the comparison of OSSAS scores by subject report of oily
skin severity as rated by the PGI-S. Because of small sample sizes,
Table 1 Cross-sectional validation study baseline demographic and
clinical characteristics
Characteristic
Total sample
(N = 196)
Gender n (%)
Male 53 (27.2)
Female 142 (72.8)
Missing data 1
Age
Mean (SD) 36.7 (12.14)
Range 18.0–70.0
Ethnicity
White/Caucasian 119 (58.91)
African American 24 (11.88)
Hispanic/Spanish American 9 (4.46)
Asian/Oriental or Paciﬁc Islander 3 (1.49)
Other 3 (1.49)
Missing data 38 (19.38)
Which is the most bothersome oily area of your face?
n (%)
Forehead 81 (42.40)
Nose area 80 (41.88)
Chin 16 (8.38)
Cheeks 14 (7.33)
Missing data 5
On average, would you say that the oiliness of your skin is:
n (%)
Mild 19 (9.8)
Moderate 124 (63.9)
Severe 45 (23.2)
Missing data 8 (4)
Do you have acne? n (%)
Yes 125 (64.4)
No 56 (28.9)
Missing data 15 (7.7)
Currently is your acne n (%)
Mild 65 (33.2)
Moderate 55 (28.1)
Severe 15 (8.7)
Extreme 0 (0.0)
Missing data 61 (31.1)
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some of the PGI-S levels were collapsed together in the analysis,
thus comparisons were made among the three groups: Not at
all/Mildly oily (n = 18), Moderately oily (n = 104), and Severely/
Very Severely oily (n = 61). For all of the OSSAS scales, there
were statistically signiﬁcant differences among the three col-
lapsed oily skin severity groups (P < 0.0001) (Table 3).
In addition, for all of the OSSAS scales (Sensation, Visual,
and Tactile) and the Blotting item, subjects who reported having
“Severely/very severely oily” skin had higher (i.e., worse) OSSAS
scores than subjects who reported having moderate, mild, or no
oily skin (Table 3). However, contrary to expectations, subjects
who reported having “Not at all/Mildly oily” skin also had
slightly worse (higher) OSSAS scores than subjects in the “Mod-
erately oily” group. These results should be interpreted with
caution because of the small sample size of the “Not at all/
Mildly” group (n = 18).
For the comparisons of OSSAS scale scores by clinician-rated
oiliness and subject-rated bother, the expected patterns of higher
(worse) OSSAS scores for worse clinician-rated oily skin and
worse subject rated-bother were obtained with statistically sig-
niﬁcant differences among the groups (P < 0.0001; Table 3).
Finally, Pearson’s correlations between OSSAS scores and
their averaged sebumeter scores were examined at visit 1. The
sebumeter scores and the Sensation scale scores failed to correlate
(r = 0.01), although the correlations between the sebumeter and
the OSSAS Visual, Tactile, and Blotting scores were all in the low
range (r = 0.22, r = 0.32, and r = 0.34, respectively), suggesting
there is only a limited relationship.
Item Reduction of the OSIS
Eight items were deleted from the OSIS. Items were deleted
because of redundancy with other items (ﬁve items), poor face
validity (one item), because of asking about more than one
concept in the same item (two items), or presence of a signiﬁ-
cant ﬂoor effect (one item). Based on the adolescent focus
group feedback, the OSIS response continuum was revised from
a ﬁve-point scale ranging from “Never” to “Very often” to a
10-point scale ranging from “Not at all” to “Extremely.” Fol-
lowing item reduction, the conceptual framework of the OSIS
was revised; the ﬁnal OSIS conceptual framework is provided
in Figure 2.
OSIS Psychometric Validation
Construct validity. Table 4 outlines the results of the maximum
likelihood factor analysis, which was performed on the ﬁnal
Facial Oily Skin 
Severity
Blotting
35. How oily is the blotting 
paper?
Tactile
Sensations
26. How slippery is your skin 
when stroked?
31. How sticky is your skin 
when touched?
28. How oily do your fingers 
feel after stroking your skin?
33. Overall, how oily does your 
skin seem when stroked?
13. Overall how uncomfortable 
does your skin feel?
11. How heavy does your skin 
feel?
8. How unclean does your skin 
feel?
14. Overall, without touching or 
looking at your skin, how oily 
does your skin feel?
How greasy does your face 
feel?*
Visual
16. How shiny is your skin?
19. How moist does the skin 
surface look?
24. Overall, how oily does your 
skin look?
How oily is the skin on 
your face?*
* New items added to the OSSAS 
during the item reduction process
Figure 1 OSSAS conceptual framework.
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OSIS items to establish the scoring of the instrument. All items
performed well, loading at a level of >0.30 with one factor. Three
items asking about the annoyance/irritability of oily skin loaded
most highly on the ﬁrst factor (factor coefﬁcients of 0.77, 0.73
and 0.57, respectively) and were included on the Annoyance
scale. The three remaining items loaded most highly on the
second factor (coefﬁcients of 0.84, 0.75 and 0.52, respectively)
and were included in the Self-Image scale.
All items met the criterion for item convergent validity (item-
scale correlations >0.40), with item scale correlations ranging
from 0.60 to 0.78 (Table 4). All items were found to correlate
more highly with their own scale than with the other OSIS
scale—thus the criterion for item discriminant validity was
satisﬁed.
The correlation between the two scales of the OSIS was
moderate (r = 0.75), suggesting that the scales are measuring
concepts that are related but not redundant (Table 4). The per-
centages of subjects scoring at ﬂoor (lowest possible score) and
ceiling (highest possible score) were low for both of the scales
and so were acceptable.
Reliability. The internal consistency reliability results for the
OSIS were excellent, with Cronbach’s alpha coefﬁcients of 0.87
for the Self-Image scale and 0.82 for the Annoyance scale
(Table 4).
Deﬁning stable subjects as those who reported no change
on the PGI, the standard for acceptable test–retest reliability
(ICC  0.70) [24] was surpassed by the Annoyance scale
(ICC = 0.74) but the result for the Self-Image scale fell just below
the a priori threshold (ICC = 0.69).
Concurrent validity. Correlations between OSIS scores and
Skindex-29 scores ranged from r = 0.37 to r = 0.73. Both the
OSIS Self-Image and Annoyance scales correlating most highly
with the Skindex-29 Emotions scale (r = 0.69 and r = 0.73). Cor-
relations with the Acne-QoL ranged from r = -0.48 to r = -0.73,
with the OSIS Self-Image scale correlating most highly with the
Self-Perception scale (r = -0.67) and the OSIS Annoyance scale
correlating at the highest level with the Role-emotional scale
(r = -0.73). These results make sense when considering the
content of the scales.
Known groups validity. Known group validity results for the
OSIS are presented in Table 5. For both scales, there was a clear
pattern of higher OSIS scores (indicated greater emotional
impact of oily skin) for subjects who reported being more both-
ered by their oily skin (P < 0.0001).
OSIS scores were also compared according to subjects’ self-
reported oily skin severity on the PGI-S (Table 5). Subjects who
rated their facial skin as more oily on the PGI-S scored worse on
the OSIS Annoyance scale (P < 0.001). For the Self-Image scale,
although there were statistically signiﬁcant differences among the
three groups (P < 0.001), the expected pattern of results was not
found—subjects who rated their skin as “Moderately oily”
scored better on the Self-Image scale than subjects who rated
their skin as “Not at all/Mildly oily.” However, the results should
be interpreted with caution because of the small sample size
(n = 18) of the “Mildly/Not at all” oily group.
Discussion
When patients present to dermatologists with a complaint of oily
skin, the clinician generally relies on the patient’s report regard-
ing the severity and impact of the condition. The use of PRO
measures such as the OSSAS and OSIS is one way to attempt toTa
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standardize patients’ reports of their condition, allowing for
valid and reliable measurement in large studies such as clinical
trials. The study reported here provides initial evidence of strong
validity and internal consistency for the OSSAS and OSIS in this
sample of adults with oily facial skin.
Following item reduction, psychometric validation of the
OSSAS suggests that the three hypothesized multiitem scales and
the single blotting item have strong construct validity. Factor
analysis results were strong with almost all items loading on
factors corresponding to the domains in which they were
included, and none of the items loaded on more than one factor.
Multitrait analysis showed that all items also correlated with the
domains in which they were included and all three multiitem
scales showed high internal consistency. Of some concern, the a
priori threshold for test–retest reliability was only met by the
Sensation scale although the Tactile and Visual domains and
Blotting item were all approaching this threshold and should not
be considered poor. The reasons for these test–retest reliability
results are unclear—one possibility is that the subjects’ oily skin
was more variable than predicted, and results could possibly be
improved by shortening the timeframe between ﬁrst and second
visits for this assessment. It is hoped that proposed changes to the
instructions and format of the OSSAS may lead to improvements
in test–retest reliability; further testing of test–retest reliability is
required to verify this.
Correlations of the OSSAS domains with those of the
Skindex-29 and Acne-QoL were all small, but this makes sense
given that these measures are all assessing quite different con-
cepts. Other similar measures to the OSSAS which might have
provided better results for concurrent validity were not available
at the time of this study [9]. In general, the discriminative or
“known groups” validity results suggest the OSSAS is able to
discriminate among known groups. The expected pattern of
results was achieved for four of the ﬁve discriminative validity
criteria evaluated. Only the comparison of scores for subject
rating of severity did not yield the expected pattern, but this may
Table 3 OSSAS known groups analyses
OSSAS domain score
Sensation Visual Tactile Blotting
Mean (SD)
n
Mean (SD)
n
Mean (SD)
n
Mean (SD)
n
Patient Global Impression of Severity (PGI-S)*
Not at all/Mildly 58.1 (19.94) 61.9 (16.62) 64.1 (17.88) 3.4 (1.38)
18 18 18 18
Moderately 56.3 (14.14) 60.3 (11.14) 60.5 (12.58) 3.2 (0.83)
104 103 103 104
Severely/Very severely 69.8 (14.96) 71.2 (15.98) 74.8 (15.01) 4.1 (0.83)
61 60 61 61
P value (ANOVA) <0.0001 <0.0001 <0.0001 <0.0001
Subject self-assessment of skin oiliness†
Mild 50.7 (11.24) 57.2 (8.82) 56.1 (10.77) 3.0 (0.96)
29 29 29 29
Moderate 61.2 (15.55) 63.4 (14.03) 65.4 (14.23) 3.4 (0.96)
137 135 136 136
Severe 73.8 (17.41) 72.9 (14.84) 79.3 (2.88) 4.3 (0.75)
28 28 28 28
P value (ANOVA) <0.0001 <0.0001 <0.0001 <0.0001
Subject self-assessment of bother‡
Somewhat bothered 53.5 (14.12) 58.9 (11.29) 59.1 (13.79) 3.0 (0.92)
78 78 78 77
Very bothered 65.8 (14.31) 66.6 (13.24) 69.7 (13.04) 3.8 (0.88)
97 95 96 97
Extremely bothered 72.1 (21.49) 70.2 (21.59) 76.1 (19.54) 4.1 (1.03)
19 19 19 19
P value (ANOVA) <0.0001 <0.0001 <0.0001 <0.0001
CGI-S nose area§
Mildly 53.3 (10.33) 57.8 (13.11) 56.7 (13.82) 3.0 (1.67)
6 6 6 6
Moderately 58.5 (14.91) 60.7 (11.72) 61.5 (13.95) 3.4 (0.85)
51 51 50 50
Severely 65.7 (16.22) 71.0 (15.93) 73.0 (14.98) 3.7 (0.90)
21 20 21 21
P value (ANOVA) 0.1018 0.0086 0.0046 0.2017
CGI-S forehead area
Mildly 60.5 (14.91) 55.2 (10.37) 58.2 (13.36) 3.0 (1.00)
11 11 11 11
Moderately 59.7 (16.80) 65.0 (11.24) 65.3 (12.92) 3.5 (0.85)
35 35 35 35
Severely 62.9 (16.93) 65.6 (17.98) 69.7 (16.68) 4.0 (1.14)
24 24 24 24
Very severely 74.5 (17.10) 73.9 (18.96) 80.6 (15.62) 4.1 (0.94)
11 11 11 11
P value (ANOVA) 0.0840 0.0333 0.0035 0.0128
Correlation with sebumeter assessment 0.01 0.22 0.32 0.34
*As deﬁned by the PGI-S assessment (subjects rate their own level of skin oiliness on a 5-point scale ranging from “Not at all oily” to “Very Severely Oily”).
†Subject rates level of skin oiliness on a scale of “mild,” “moderate,” and “severe.” No deﬁnitions for the categories were provided; this was left to patient interpretation.
‡Subjects rate how bothered they are by their oily skin on a 5-point scale ranging from “Not at all bothered” to “Extremely bothered.”
§Clinician rating of the severity of skin oiliness in a particular area on a 5-point scale from “Not at all oily” to “Extremely oily.”
ANOVA, analysis of variance; CGI-S, Clinical Global Impression of Severity.
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be because of collapsing the groups or the small sample size of
the “Not at all/Mildly oily” group (n = 18). Further testing of
discriminative validity in a larger sample is recommended in
future studies.
All of the OSSAS scales had low correlations with the sebu-
meter. As the validity of the sebumeter has not been demon-
strated, it is difﬁcult to interpret this result. It may indicate that
the PRO rating is partly affected by psychological issues as well
as the objective level of oiliness. Arguably, the low correlations
indicate that it is important to include both clinical and patient-
reported measures of facial oiliness as end points in any study.
Analyses suggested that both OSIS domain scores have strong
psychometric properties. All OSIS items performed well in
the factor analysis with only one item asking about Self-
consciousness loading on two factors. However, the item loaded
most highly on the Self-Image factor, on which it was ultimately
placed; therefore, this result is not of concern. All items met the
criterion for both item convergent validity and item discriminant
validity and results for internal consistency reliability were excel-
lent, with Cronbach’s alpha coefﬁcients well above the recom-
mended threshold (0.70) for both scales. A result of slight
concern for the OSIS was the test–retest reliability of the Self-
Image scale, which fell marginally below the threshold of 0.70
for acceptability.
The correlations of the OSIS domains with the Skindex-29
and Acne-QoL made sense in terms of the face validity of the
scales (scales measuring similar concepts correlated highly, cor-
relations among other scales were small), thus providing evidence
of satisfactory concurrent validity. The OSIS also showed the
ability to discriminate between groups that would be expected to
differ. When the OSIS scale scores were compared by self assess-
ment of skin oiliness, CGI-S scores and subject report of bother-
someness of their oily skin, the expected pattern of results was
seen for the Annoyance scale in all cases, and for three out of the
ﬁve assessments for the Self-Image scale. In both cases where the
expected pattern of results was not seen (PGI-S rating and CGI-S
forehead), there were very small sample sizes, and so the results
should be interpreted with caution.
The low correlations between the OSIS and sebumeter are
unsurprising, given that the sebumeter measurement is taken at
the point of the clinic visit, where the OSIS asks the subject to
think back “over the past week.”
Psychometric validation was performed on data collected
from male and female adult participants who had a range of
oiliness severity levels from mild to severe and some of who had
acne in addition to their oily skin. Thus, evidence has been
presented to suggest that the instruments are appropriate for use
in adults with differing levels of oily skin severity and with or
without acne.
In recent months, the Oily Skin Self-Image Questionnaire
(OSSIQ), developed in French for use in women with oily skin,
has been published [9]. Although also being speciﬁc to oily skin,
the OSSIQ has quite a different focus compared to both the
OSSAS and OSIS. It includes content most closely related to the
concepts measured by the OSIS (Self-Image and Annoyance), but
focuses on more depressive and anxious feelings arising from oily
skin (e.g., “my skin makes me feel depressed” and “my skin
problem is stressful”), with only a few items asking about Self-
Image, and none asking about Annoyance related to oily skin. In
addition, it should be noted that the OSSIQ is concerned with
oily skin in general, whereas the OSSAS and OSIS are focused on
only oily facial skin. Thus, the instruments could be considered
to be complementary rather than redundant: Where a measure of
the experience and severity of oily facial skin is required, the
OSSAS might be the most appropriate instrument; if an assess-
ment of the psychosocial impact of oily skin in general is
required, use of the OSSIQ might be appropriate; if a measure of
self image and annoyance related to facial oily skin is of interest,
then the OSIS might be preferred.
Limitations and Further Research
This study was performed in a sample of native English speakers
in the United States; it would be necessary for further validation
to be performed in other languages and cultures to conﬁrm the
cross-cultural validity of the instrument. A further limitation was
the absence of a well-validated clinical measure against which the
PRO scores could be compared for clinical validity. Thus far, the
sebumeter, against which the measures were assessed, has only
limited evidence of validity [28] and therefore results should be
interpreted with caution.
In this study, subjects were asked to follow a number of
lifestyle guidelines, in order to reduce variability in their oily skin
rating because of covariates such as sweating as a result of
Impact of 
Oily Skin 
Symptoms
Self image/Self concept
1. Unattractive 
2.Embarrassed 
6. Self-conscious 
3. Frustrated 
4. Annoyed
5. Irritated
Annoyance
Over the past week, how much did the 
oiliness of your face make you feel:
Over the past week, how much did the oiliness of 
your face make you feel :
Figure 2 OSIS conceptual framework.
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physical exertion or variations in lighting conditions. It is antici-
pated that similar guidelines would be followed in any clinical
trials that might use the instruments as end points, in order to
ensure any changes in scores are because of true changes in oily
skin severity, rather than changes in environmental conditions or
other covariates. However, the validity ﬁndings reported here
might not generalize to situations in which it is not feasible to
control these covariates, such as general clinical practice. In such
instances, further validation might be recommended through a
study that employs a more naturalistic study design in which
these variables are not controlled.
Responsiveness and minimal important differences have not
yet been examined for the OSSAS and OSIS. These properties
could not be assessed in this validation study as subjects received
no treatment and therefore were not expected to experience a
change in their oily skin.
Following comments given by the adolescent subjects and
discussions during item reduction, the focus of the OSSAS was
changed from assessing the most bothersome area of the face to
the assessment of the whole face. Additionally, the response
options of both measures were changed from ﬁve-point Likert
scales to anchored, 0 to 10 numerical rating scales. Further
cognitive debrieﬁng to test face and content validity of the instru-
ments with these revisions is recommended to ensure items
are still comprehensible and acceptable to both adults and
adolescents.
Conclusions
The versions of the OSSAS and OSIS tested in this study have
been shown to have strong psychometric properties in thisTa
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Table 5 OSIS known groups analyses
OSIS domain scores
Self-Image Annoyance
Mean (SD)
n
Mean (SD)
n
Subject self-assessment of bother*
Somewhat bothered 50.3 (17.48) 44.1 (16.93)
78 78
Very bothered 66.9 (17.96) 61.2 (17.41)
97 94
Extremely bothered 77.9 (23.31) 78.9 (16.22)
19 19
P value (ANOVA) <0.0001 <0.0001
Patient Global Impression Severity (PGI-S)†
Not at all/Mildly oily 59.6 (25.31) 51.5 (22.50)
18 18
Moderately Oily 57.6 (19.04) 52.1 (18.95)
104 104
Severely/Very severely oily 71.3 (18.32) 67.6 (17.99)
61 58
P value (ANOVA) <0.0001 <0.0001
Subject self-assessment of skin oiliness‡
Mild 51.0 (19.05) 46.4 (18.81)
29 29
Moderate 61.0 (20.12) 55.4 (18.81)
137 134
Severe 73.6 (18.64) 68.6 (17.86)
28 28
P value (ANOVA) <0.0001 <0.0001
*Subjects rate how bothered they are by their oily skin on a 5-point scale ranging from “Not
at all bothered” to “Extremely bothered.”
†As deﬁned by the PGI-S assessment (subjects rate their own level of skin oiliness on a
5-point scale ranging from “Not at all oily” to “Very Severely Oily”).
‡Subject rates level of skin oiliness on a scale of “mild,” “moderate,” and “severe.” No
deﬁnitions for the categories were provided; this was left to patient interpretation.
ANOVA, analysis of variance.
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sample of adults with self-reported oily facial skin. Results
suggest they provide valid measures of self-reported oily facial
skin severity and its emotional impact, respectively. Further
testing is required to deﬁne minimal important differences for the
instruments and ensure they have the ability to detect change in
facial oil over time.
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